Britta Weigelt

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• The Genomic Landscape of <i>MYC</i> , <i>MYCL</i> , and <i>MYCN</i> Amplified Solid Tumors

  Clinical Cancer Research · 2026-06-24

• Supplementary Table S1 from A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number–High/p53-Abnormal Endometrial Cancer

  2026-06-15

• Supplementary Table S2 from A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number–High/p53-Abnormal Endometrial Cancer

  2026-06-15

• Data from A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number–High/p53-Abnormal Endometrial Cancer

  2026-06-15

• Supplementary Figure S2 from A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number–High/p53-Abnormal Endometrial Cancer

  2026-06-15

• Supplementary Figure S1 from A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number–High/p53-Abnormal Endometrial Cancer

  2026-06-15

• Molecular subtype assignment in endometrial carcinoma: Challenging cases and the role of panel sequencing

  Gynecologic Oncology · 2026-04-23

• Natural language processing compared with skilled human curation in determining radiologic progression for ovarian cancer

  Gynecologic Oncology · 2026-04-23

• Molecular characterization of low-grade serous ovarian carcinoma lacking MAPK-pathway alterations

  Gynecologic Oncology · 2026-04-23

• The impact of cervical stromal involvement on survival outcomes in stage IIIC endometrial carcinoma

  Gynecologic Oncology · 2026-04-23

• Impact of CCNE1 amplification on progression-free and overall survival among patients with newly diagnosed ovarian cancer without a BRCA mutation

  Gynecologic Oncology · 2026-04-23

• Adjuvant dostarlimab with pelvic radiation (RT) in locally advanced, mismatch repair-deficient (MMR-D) endometrial cancer (EC): D-RT study

  Gynecologic Oncology · 2026-04-23

• Mismatch repair deficiency and mutational landscapes of endometrial hyperplasia and associated endometrial endometrioid carcinoma

  Gynecologic Oncology · 2026-04-23

• Endometrial carcinomas with unusual molecular profiles: Experience from prospective clinical panel sequencing

  Gynecologic Oncology · 2026-04-23

• ADC target expression in primary and matched recurrent high-grade endometrial carcinomas

  Gynecologic Oncology · 2026-04-23

• Stress cytokine release during surgery for early cervical cancer

  Gynecologic Oncology · 2026-04-23

• Multimodal predictors of recurrence in patients with germline BRCA1/2-associated ovarian cancer receiving frontline PARP inhibitor maintenance

  Gynecologic Oncology · 2026-04-23

• Age at ovarian cancer diagnosis varies by lynch syndrome gene: A genetic testing laboratory registry study

  Gynecologic Oncology · 2026-04-23

• Germline Pathogenic Variants in Homologous Recombination Pathway Genes Are Frequent in Pancreatobiliary Ampullary Carcinoma

  JCO Precision Oncology · 2026-04-01

• A convergent uPAR-positive tumor ecosystem creates broad vulnerability to CAR T cell therapy

  Cell · 2026-03-30 · 5 citations